FI873409A0 - Oralt terapeutiskt system med systemisk verkan. - Google Patents

Oralt terapeutiskt system med systemisk verkan.

Info

Publication number
FI873409A0
FI873409A0 FI873409A FI873409A FI873409A0 FI 873409 A0 FI873409 A0 FI 873409A0 FI 873409 A FI873409 A FI 873409A FI 873409 A FI873409 A FI 873409A FI 873409 A0 FI873409 A0 FI 873409A0
Authority
FI
Finland
Prior art keywords
oralt
therapeutic
network
system network
therapeutic system
Prior art date
Application number
FI873409A
Other languages
English (en)
Other versions
FI86143C (fi
FI873409A (fi
FI86143B (fi
Inventor
Satish Chandra Khanna
Theresa Ruettimann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI873409A0 publication Critical patent/FI873409A0/fi
Publication of FI873409A publication Critical patent/FI873409A/fi
Application granted granted Critical
Publication of FI86143B publication Critical patent/FI86143B/fi
Publication of FI86143C publication Critical patent/FI86143C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI873409A 1986-08-07 1987-08-05 Foerfarande foer framstaellning av ett oralt, terapeutiskt system. FI86143C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.
CH317286 1986-08-07

Publications (4)

Publication Number Publication Date
FI873409A0 true FI873409A0 (fi) 1987-08-05
FI873409A FI873409A (fi) 1988-02-08
FI86143B FI86143B (fi) 1992-04-15
FI86143C FI86143C (fi) 1992-07-27

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873409A FI86143C (fi) 1986-08-07 1987-08-05 Foerfarande foer framstaellning av ett oralt, terapeutiskt system.

Country Status (30)

Country Link
US (1) US4857336A (fi)
JP (1) JP2592460B2 (fi)
KR (1) KR950006219B1 (fi)
AT (1) AT397344B (fi)
AU (1) AU597403B2 (fi)
BE (1) BE1000235A3 (fi)
CA (1) CA1302267C (fi)
CH (1) CH668187A5 (fi)
DD (1) DD285718A5 (fi)
DE (1) DE3725824C2 (fi)
DK (1) DK175497B1 (fi)
ES (1) ES2007100A6 (fi)
FI (1) FI86143C (fi)
FR (1) FR2602425B1 (fi)
GB (1) GB2193632B (fi)
GR (1) GR871234B (fi)
HK (1) HK33793A (fi)
HU (1) HU206978B (fi)
IE (1) IE59718B1 (fi)
IL (1) IL83386A (fi)
IT (1) IT1215618B (fi)
LU (1) LU86966A1 (fi)
MY (1) MY100767A (fi)
NL (1) NL194780C (fi)
NO (1) NO173726C (fi)
NZ (1) NZ221347A (fi)
PH (1) PH25090A (fi)
PT (1) PT85489B (fi)
SE (1) SE502590C2 (fi)
ZA (1) ZA875804B (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE72111T1 (de) * 1987-01-14 1992-02-15 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
DE69227240T2 (de) * 1991-01-16 1999-04-08 Fmc Corp., Philadelphia, Pa. Träger für wirkstoffe und damit hergestellte feste darreichungsformen
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
US6270799B1 (en) 1997-09-25 2001-08-07 Bayer Aktiengesellscahft Medicament formulation with a controlled release of an active agent
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
WO1999055312A2 (en) * 1998-04-29 1999-11-04 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
IN190699B (fi) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
JP5328071B2 (ja) * 2001-04-10 2013-10-30 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 時限パルス放出組成物
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
TW200302748A (en) * 2002-02-01 2003-08-16 Pfizer Prod Inc Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
AU2003231919A1 (en) * 2002-03-14 2003-09-22 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
US20060275367A1 (en) * 2005-04-25 2006-12-07 Shubha Chungi Extended release formulations
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
DK2054031T3 (en) 2006-07-21 2016-05-17 Biodelivery Sciences Int Inc Transmucosal delivery devices with improved uptake
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
EP2240162A4 (en) 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
KR101944367B1 (ko) 2011-08-18 2019-01-31 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 부프레노르핀 운반용 약물남용 억제 점막 부착 장치
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Also Published As

Publication number Publication date
FI86143C (fi) 1992-07-27
IL83386A0 (en) 1987-12-31
DK410787D0 (da) 1987-08-06
PT85489B (pt) 1990-06-29
PH25090A (en) 1991-02-19
GR871234B (en) 1987-12-08
BE1000235A3 (fr) 1988-09-20
IL83386A (en) 1992-01-15
IE59718B1 (en) 1994-03-23
SE8703034L (sv) 1988-02-08
GB2193632A (en) 1988-02-17
NO173726C (no) 1994-01-26
FR2602425A1 (fr) 1988-02-12
FI873409A (fi) 1988-02-08
NO873298D0 (no) 1987-08-06
SE8703034D0 (sv) 1987-08-03
CH668187A5 (de) 1988-12-15
DE3725824A1 (de) 1988-02-11
AU597403B2 (en) 1990-05-31
FR2602425B1 (fr) 1990-09-14
JPS6344525A (ja) 1988-02-25
NL8701857A (nl) 1988-03-01
US4857336A (en) 1989-08-15
NZ221347A (en) 1989-12-21
HU206978B (en) 1993-03-01
ATA199387A (de) 1993-08-15
ZA875804B (en) 1988-02-08
NO173726B (no) 1993-10-18
JP2592460B2 (ja) 1997-03-19
IT8748270A0 (it) 1987-08-05
KR950006219B1 (ko) 1995-06-12
SE502590C2 (sv) 1995-11-20
GB2193632B (en) 1990-04-25
MY100767A (en) 1991-02-14
CA1302267C (en) 1992-06-02
FI86143B (fi) 1992-04-15
NO873298L (no) 1988-02-08
HK33793A (en) 1993-04-16
DE3725824C2 (de) 1998-12-17
IT1215618B (it) 1990-02-22
DD285718A5 (de) 1991-01-03
DK410787A (da) 1988-02-08
PT85489A (en) 1987-09-01
IE872110L (en) 1988-02-07
AT397344B (de) 1994-03-25
AU7661787A (en) 1988-02-11
GB8717643D0 (en) 1987-09-03
KR880002511A (ko) 1988-05-09
LU86966A1 (fr) 1989-03-08
NL194780C (nl) 2003-03-04
HUT44930A (en) 1988-05-30
DK175497B1 (da) 2004-11-15
ES2007100A6 (es) 1989-06-01
NL194780B (nl) 2002-11-01

Similar Documents

Publication Publication Date Title
FI873409A0 (fi) Oralt terapeutiskt system med systemisk verkan.
MX9203418A (es) Nucleosidos terapeuticos.
FI894688A (fi) Flytande oralt tagbart terapeutiskt system.
FI862627A0 (fi) System foer reglerande av en krans hastighet.
FI872808A (fi) Nya topiskt applicerbara farmaceutiska sammansaettningar med systemisk verkan.
DE3852710D1 (de) Therapeutische Nukleoside.
FI875098A (fi) Transdermalt terapeutiskt system.
FI875039A (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
FI870980A (fi) Atomreaktor foersedd med i laengdriktningen laongstraeckt kaerl.
DE3787252D1 (de) Ortungssystem.
FI865069A (fi) Terapeutiskt system.
FI864526A0 (fi) Foerfarande foer tillvaratagande av vaerme i samband med en gasturbinprocess.
NO880055D0 (no) Lokaliseringssystem.
FI862296A0 (fi) Tvaokomponentburk med perforeringsorgan.
DK175988A (da) Byggesystem
DK206488D0 (da) Fluorescenslampe-belysningssystem
FI862763A0 (fi) Plasmaprocessenhet med cellstruktur.
FI860263A (fi) Med undertryck fungerande faestunderlag.
DE3769151D1 (de) Bausystem.
SE8605162D0 (sv) Lokvarnings-system
SE8600660D0 (sv) System
FI864851A0 (fi) System foer tillvaratagning av vaerme.
FI860560A0 (fi) System av traeelement foer monterbara moebler.
FI860716A0 (fi) System foer foerhindrande av blaendning.
FI862812A0 (fi) System foer koncentration av solstraolning.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired